Resurrecting DNAzymes as sequence-specific therapeutics.

Abstract

In a mouse model of skin cancer, intratumoral injection of a sequence-specific mRNA-cleaving DNA enzyme caused potent inhibition of tumor growth and unusually benign pharmacodynamic profiles. 
DOI: 10.1126/scitranslmed.3004080

1 Figure or Table

Topics

  • Presentations referencing similar topics